{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:26:49Z","timestamp":1790015209093,"version":"4.0.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2019.00535","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:58:37Z","timestamp":1552957117000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Subtype-Specific Prevalence of Hepatitis C Virus NS5A Resistance Associated Substitutions in Mainland China"],"prefix":"10.3389","volume":"10","author":[{"given":"Jie","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/apt.12646","article-title":"Review article: HCV genotype 3 - the new treatment challenge.","volume":"39","author":"Ampuero","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/v8040091","article-title":"Frequency of natural resistance within NS5a replication complex domain in hepatitis C genotypes 1a, 1b: possible implication of subtype-specific resistance selection in multiple direct acting antivirals drugs combination treatment.","volume":"8","author":"Bagaglio","year":"2016","journal-title":"Viruses"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.cmi.2017.08.003","article-title":"Natural NS5A inhibitor resistance associated substitutions in hepatitis C virus genotype 1 infected patients from Italy.","volume":"24","author":"Caudai","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2017.77","article-title":"Hepatitis C virus genotypes and subtypes circulating in Mainland China.","volume":"6","author":"Chen","year":"2017","journal-title":"Emerg. Microbes Infect."},{"key":"B5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/IDR.S145362","article-title":"Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients.","volume":"10","author":"Chen","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"B6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jhep.2017.09.008","article-title":"Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: what are the chances for second-line regimens?","volume":"68","author":"Di Maio","year":"2018","journal-title":"J. Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1053\/j.gastro.2017.11.007","article-title":"Patterns of resistance-associated substitutions in patients with chronic HCV infection following treatment with direct-acting antivirals.","volume":"154","author":"Dietz","year":"2017","journal-title":"Gastroenterology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/3-540-26397-7_3","article-title":"Viruses as quasispecies: biological implications.","volume":"299","author":"Domingo","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/bioinformatics\/btq461","article-title":"Search and clustering orders of magnitude faster than BLAST.","volume":"26","author":"Edgar","year":"2010","journal-title":"Bioinformatics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"EASL Recommendations on Treatment of Hepatitis C 2016.","volume":"66","year":"2017","journal-title":"J. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2820-z","article-title":"Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic review.","volume":"17","author":"Fathi","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028006","article-title":"HCV 6a prevalence in guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses.","volume":"7","author":"Fu","year":"2012","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2893.2010.01280.x","article-title":"New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors.","volume":"18","author":"Fu","year":"2011","journal-title":"J. Viral. Hepat."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1053\/j.gastro.2017.12.015","article-title":"Efficacy of NS5A inhibitors against hepatitis C virus genotypes 1-7 and escape variants.","volume":"154","author":"Gottwein","year":"2018","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection.","volume":"61","author":"Gower","year":"2014","journal-title":"J. Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1478-3231.2011.02716.x","article-title":"Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?","volume":"32","author":"Halfon","year":"2012","journal-title":"Liver Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jcv.2012.12.020","article-title":"Natural prevalence of NS5A polymorphisms in subjects infected with hepatitis C virus genotype 3 and their effects on the antiviral activity of NS5A inhibitors.","volume":"57","author":"Hernandez","year":"2013","journal-title":"J. Clin. Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3760\/cma.j.issn.1007-3418.2016.11.015","article-title":"[Current status of treatment of chronic hepatitis C and related challenges in the \u201cPre-DAA Era\u201d in China].","volume":"24","author":"Hu","year":"2016","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155869","article-title":"Geno2pheno[HCV] - a web-based interpretation system to support hepatitis C treatment decisions in the era of direct-acting antiviral agents.","volume":"11","author":"Kalaghatgi","year":"2016","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jhep.2012.11.012","article-title":"Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir.","volume":"58","author":"Karino","year":"2013","journal-title":"J. Hepatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/molbev\/msy096","article-title":"MEGA X: molecular evolutionary genetics analysis across computing platforms.","volume":"35","author":"Kumar","year":"2018","journal-title":"Mol. Biol. Evol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1128\/AAC.00763-16","article-title":"Clinical resistance to velpatasvir (GS-5816), a novel pan-genotypic inhibitor of the hepatitis C virus NS5A protein.","volume":"60","author":"Lawitz","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkw290","article-title":"Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees.","volume":"44","author":"Letunic","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2147\/IDR.S146595","article-title":"Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-naive hepatitis C genotype 1b-infected patients in western China.","volume":"10","author":"Li","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"B25","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.1128\/AAC.01390-15","article-title":"Susceptibilities of genotype 1a, 1b, and 3 hepatitis C virus variants to the NS5A inhibitor elbasvir.","volume":"59","author":"Liu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/jmv.24894","article-title":"Younger trend of cirrhosis incidence in genotype 3 HCV infected patients in Eastern China.","volume":"89","author":"Lu","year":"2017","journal-title":"J. Med. Virol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105569","article-title":"Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing.","volume":"9","author":"Margeridon-Thermet","year":"2014","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1128\/JVI.66.5.3225-3229.1992","article-title":"Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.","volume":"66","author":"Martell","year":"1992","journal-title":"J. Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes.","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1099\/vir.0.81360-0","article-title":"Population genetic history of hepatitis C virus 1b infection in China.","volume":"87","author":"Nakano","year":"2006","journal-title":"J. Gen. Virol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens.","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.10.005","article-title":"Quasispecies dynamics and clinical significance of HCV antiviral resistance.","author":"Perales","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.antiviral.2015.01.003","article-title":"Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region.","volume":"116","author":"Sarrazin","year":"2015","journal-title":"Antiviral Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.","volume":"42","author":"Simmonds","year":"2005","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29837","article-title":"Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors.","author":"Smith","year":"2018","journal-title":"Hepatology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1080\/14656566.2017.1346609","article-title":"Treatment of hepatitis C with new fixed dose combinations.","volume":"18","author":"Soriano","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cid\/ciu697","article-title":"Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials.","volume":"59","author":"Svarovskaia","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/oxfordjournals.molbev.a040023","article-title":"Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees.","volume":"10","author":"Tamura","year":"1993","journal-title":"Mol. Biol. Evol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jcv.2017.04.008","article-title":"A genotype independent, full-genome reverse-transcription protocol for HCV genotyping and resistance testing.","volume":"91","author":"Walker","year":"2017","journal-title":"J. Clin. Virol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.4103\/0366-6999.166038","article-title":"Direct-acting antiviral agents resistance-associated polymorphisms in chinese treatment-naive patients infected with genotype 1b hepatitis C virus.","volume":"128","author":"Wang","year":"2015","journal-title":"Chin. Med. J."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2018-000209","article-title":"Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia.","volume":"5","author":"Wei","year":"2018","journal-title":"BMJ Open Gastroenterol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.antiviral.2018.08.001","article-title":"HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI-Resistance associated substitutions in HCV-Infected patients in Mainland China.","volume":"158","author":"Wei","year":"2018","journal-title":"Antiviral Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jhep.2017.03.014","article-title":"Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses.","volume":"67","author":"Welzel","year":"2017","journal-title":"J. Hepatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3851\/IMP3149","article-title":"In vitro selection of resistance to sofosbuvir in HCV replicons of genotype-1 to -6.","volume":"22","author":"Xu","year":"2017","journal-title":"Antivir. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1159\/000481561","article-title":"Genotype distribution and molecular epidemiology of hepatitis C virus in guangzhou, china: predominance of genotype 1b and increasing incidence of genotype 6a.","volume":"43","author":"Yuan","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jhep.2017.01.007","article-title":"NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome.","volume":"66","author":"Zeuzem","year":"2017","journal-title":"J. Hepatol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165658","article-title":"Pre-Existing HCV Variants Resistant to DAAs and Their Sensitivity to PegIFN\/RBV in Chinese HCV Genotype 1b Patients.","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1093\/jac\/dkw336","article-title":"Characterization of NS5A polymorphisms and their impact on response rates in patients with HCV genotype 2 treated with daclatasvir-based regimens.","volume":"71","author":"Zhou","year":"2016","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.00535\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T17:25:51Z","timestamp":1606843551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.00535\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":49,"alternative-id":["10.3389\/fmicb.2019.00535"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2019.00535","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"article-number":"535"}}